|
|
||||||||
Departments of Neurology (Dr. Stern, D. Hesdorffer, and Drs. Sano and Mayeux) and Psychiatry (Drs. Stern and Mayeux), Columbia University College of Physicians and Surgeons, New York, NY.
Functional loss in Alzheimer's disease is difficult to measure or predict. The Blessed Dementia Rating Scale (Part 1) correlates well with postmortem changes but is not an effective antemortem index of functional change since disparate behavorial domains are assessed. We performed a factor analysis of the Blessed items in 187 patients with clinically diagnosed Alzheimer's disease and identified 4 independent factors: (I) cognitive, (II) personality, (III) apathy, and (IV) basic self-care. An endpoint, consisting of a score indicative of moderate disability, was determined for each factor. We then used life table analyses to compare the probability of reaching these endpoints over time in longitudinally followed patients. Patients with extrapyramidal signs at their initial visit reached the factor IV endpoint sooner, and those with psychosis or no family history of dementia also reached the factor I endpoint faster. These data illustrate the utility of a multifactorial approach to the assessment of functional capacity in Alzheimer's disease, and also indicate that extrapyramidal symptoms and psychosis are powerful predictors of the rate of decline in basic self-care activities and cognition.
Address correspondence to Dr. Yaakov Stern, Neurological Institute, 710 West 168th Street, New York, NY 10032.
This work was supported by the Charles S. Robertson Memorial Gift for Alzheimer's Disease Research and by Federal Grants AG07370, AG07232, and AG08702. It was completed in the General Clinical Research Center, and data were analyzed on a CLINFO system (both RR00645).
Presented in part at the 113th annual meeting of the American Neurological Association, Philadelphia, PA, 1988.
Received May 12, 1989. Accepted for publication in final form June 23, 1989.
This article has been cited by other articles:
![]() |
M. F. Weiner, B. Davis, K. Martin-Cook, L. S. Hynan, K. C. Saine, and C. Munro Cullum A Direct Functional Measure to Help Ascertain Optimal Level of Residential Care American Journal of Alzheimer's Disease and Other Dementias, November 1, 2007; 22(5): 355 - 359. [Abstract] [PDF] |
||||
![]() |
K. Peres, V. Chrysostome, C. Fabrigoule, J. M. Orgogozo, J. F. Dartigues, and P. Barberger-Gateau Restriction in complex activities of daily living in MCI: Impact on outcome Neurology, August 8, 2006; 67(3): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Holtzer, D. J. Wegesin, S. M. Albert, K. Marder, K. Bell, M. Albert, J. Brandt, and Y. Stern The Rate of Cognitive Decline and Risk of Reaching Clinical Milestones in Alzheimer Disease Arch Neurol, August 1, 2003; 60(8): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Boyle, P. F. Malloy, S. Salloway, D. A. Cahn-Weiner, R. Cohen, and J. L. Cummings Executive Dysfunction and Apathy Predict Functional Impairment in Alzheimer Disease Am J Geriatr Psychiatry, April 1, 2003; 11(2): 214 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brickman, A. Riba, K. Bell, K. Marder, M. Albert, J. Brandt, and Y. Stern Longitudinal Assessment of Patient Dependence in Alzheimer Disease Arch Neurol, August 1, 2002; 59(8): 1304 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Tabert, S. M. Albert, L. Borukhova-Milov, Y. Camacho, G. Pelton, X. Liu, Y. Stern, and D. P. Devanand Functional deficits in patients with mild cognitive impairment: Prediction of AD Neurology, March 12, 2002; 58(5): 758 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Demers, M. Oremus, A. Perrault, N. Champoux, and C. Wolfson Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Functional and Quality of Life Scales J Geriatr Psychiatry Neurol, December 1, 2000; 13(4): 170 - 180. [Abstract] [PDF] |
||||
![]() |
D. C. Marson, S. M. Sawrie, S. Snyder, B. McInturff, T. Stalvey, A. Boothe, T. Aldridge, A. Chatterjee, and L. E. Harrell Assessing Financial Capacity in Patients With Alzheimer Disease: A Conceptual Model and Prototype Instrument Arch Neurol, June 1, 2000; 57(6): 877 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gelinas, S. Gauthier, and PamelaA. Cyrus Metrifonate Enhances the Ability of Alzheimer's Disease Patients to Initiate, Organize, and Execute Instrumental and Basic Activities of Daily Living J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 9 - 16. [Abstract] [PDF] |
||||
![]() |
C. R. Jack Jr, R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, E. G. Tangalos, and E. Kokmen Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease Neurology, October 1, 1998; 51(4): 993 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Tenser Trigeminal neuralgia: Mechanisms of treatment Neurology, July 1, 1998; 51(1): 17 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Sweet, M. Akil, B. H. Mulsant, R. Ulrich, R. E. Pasternak, and G. S. Zubenko Determinants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders J Neuropsychiatry Clin Neurosci, February 1, 1998; 10(1): 68 - 77. [Abstract] [Full Text] |
||||
![]() |
M. S. Mega, P. M. Thompson, J. L. Cummings, C. L. Back, M. L. Xu, S. Zohoori, A. Goldkorn, J. Moussai, L. Fairbanks, G. W. Small, et al. Sulcal variability in the Alzheimer's brain: Correlations with cognition Neurology, January 1, 1998; 50(1): 145 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mathieu, P. Allard, G. Gobeil, M. Girard, M. De Braekeleer, and P. Begin Anesthetic and surgical complications in 219 cases of myotonic dystrophy Neurology, December 1, 1997; 49(6): 1646 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goto, N. Kunitoku, N. Soyama, K. Yamada, A. Okamura, M. Yoshikawa, Y. Hirata, E. Uyama, and Y. Ushio Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy Neurology, September 1, 1997; 49(3): 707 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, R. C. Petersen, Y. C. Xu, S. C. Waring, P. C. O'Brien, E. G. Tangalos, G. E. Smith, R. J. Ivnik, and E. Kokmen Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease Neurology, September 1, 1997; 49(3): 786 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hokkanen and J. Launes Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 222 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nuwer Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neurophysiology Society Neurology, July 1, 1997; 49(1): 277 - 292. [Full Text] [PDF] |
||||
![]() |
W. C. Koller and E. B. Montgomery Issues in the early diagnosis of Parkinson's disease Neurology, July 1, 1997; 49(1_Suppl_1): S10 - S25. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goto, S. Matsumoto, Y. Ushio, and A. Hirano Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration Neurology, October 1, 1996; 47(4): 1032 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.Ch. Wolters, E.N.H. Jansen, H. G. Tuynman-Qua, and P. L.M. Bergmans Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease Neurology, October 1, 1996; 47(4): 1085 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Meltzer, J. K. Zubieta, J. Brandt, L. E. Tune, H. S. Mayberg, and J. J. Frost Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging Neurology, August 1, 1996; 47(2): 454 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ishigaki, S. Y. Patria, H. Nishio, M. Yabe, and M. Matsuo A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene Neurology, May 1, 1996; 46(5): 1347 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikoma, A. Samii, B. Mercuri, E. M. Wassermann, and M. Hallett Abnormal cortical motor excitability in dystonia Neurology, May 1, 1996; 46(5): 1371 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Pullman, B. Ford, B. Elibol, A. Uncini, P. C. Su, and S. Fahn Cutaneous electromyographic silent period findings in brachial dystonia Neurology, February 1, 1996; 46(2): 503 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boiardi, A. Salmaggi, and A. Silvani M-Bacod as first treatment for primary CNS lymphoma Neurology, January 1, 1996; 46(1): 286 - 286. [Full Text] [PDF] |
||||
![]() |
A. Das and F. H. Hochberg Reply from the Authors: M-Bacod as first treatment for primary CNS lymphoma Neurology, January 1, 1996; 46(1): 286 - 288. [Full Text] [PDF] |
||||
![]() |
N. Mavroudakis, J. M. Caroyer, E. Brunko, and D. Z. de Beyl Abnormal motor evoked responses to transcranial magnetic stimulation in focal dystonia Neurology, September 1, 1995; 45(9): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galasko, S.D. Edland, J. C. Morris, C. Clark, R. Mohs, and E. Koss The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).: Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years Neurology, August 1, 1995; 45(8): 1451 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Charletta, P.B. Gorelick, T.J. Dollear, S. Freels, and Y. Harris CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia Neurology, August 1, 1995; 45(8): 1456 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.N. van Schaik, P.M.M. Bossuyt, A. Brand, and M. Vermeulen Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis Neurology, August 1, 1995; 45(8): 1570 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rabey, T. A. Treves, M. Y. Neufeld, E. Orlov, and A. D. Korczyn Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease Neurology, March 1, 1995; 45(3): 432 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Growdon and J.-P. Vonsattel Case 17-1993- A 53-Year-Old Woman Who Died after Several Years of a Dementing Illness with Intermittent Generalized Seizures and Abnormal Movements of the Extremities and Head N. Engl. J. Med., April 29, 1993; 328(17): 1259 - 1266. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |